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Background: RGS21 is expressed in tastant-responsive lingual epithelium, but with unknown function.
Results: RGS21 accelerated intrinsic GTPase activity of multiple G subunits; RGS21 over- and underexpression in epithelial
cells modulated bitterant responsiveness.
Conclusion: RGS21 is a negative regulator of bitterant signal transduction.
Significance: RGS21 represents a nonreceptor regulatory component of gustatory signaling that alters sensitivity of bitterant
responsiveness in an endogenous, cellular context.
The gustatory systemdetects tastants and transmits signals to
the brain regarding ingested substances and nutrients.
Although tastant receptors and taste signaling pathways have
been identified, little is known about their regulation. Because
bitter, sweet, and umami taste receptors are G protein-coupled
receptors (GPCRs), we hypothesized that regulators of G pro-
tein signaling (RGS) proteins may be involved. The recent clon-
ing of RGS21 from taste bud cells has implicated this protein in
the regulation of taste signaling; however, the exact role of
RGS21 has not been precisely defined. Here, we sought to deter-
mine the role of RGS21 in tastant responsiveness. Biochemical
analyses confirmed in silico predictions that RGS21 acts as a
GTPase-accelerating protein (GAP) for multiple G protein 
subunits, including adenylyl cyclase-inhibitory (Gi) subunits
and those thought to be involved in tastant signal transduction.
Using a combination of in situ hybridization, RT-PCR, immu-
nohistochemistry, and immunofluorescence, we demonstrate
that RGS21 is not only endogenously expressed in mouse taste
buds but also in lung airway epithelial cells, which have previ-
ously been shown to express components of the taste signaling
cascade. Furthermore, as shown by reverse transcription-PCR,
the immortalized human airway cell line 16HBE was found to
express transcripts for tastant receptors, RGS21, and down-
stream taste signaling components. Over- and underexpression
of RGS21 in 16HBE cells confirmed that RGS21 acts to oppose
bitter tastant signaling to cAMP and calcium secondmessenger
changes. Our data collectively suggests that RGS21 modulates
bitter taste signal transduction.
G protein-coupled receptors (GPCRs)4 are a family of seven
transmembrane domain, cell-surface proteins that mediate
diverse cellular functions, from the perception of light and odor
to the physiologic effects of hormones and neurotransmitters
(1–3). These receptors are coupled to secondarymessenger sys-
tems by heterotrimeric G proteins, consisting of , , and 
subunits. G and G form an obligate heterodimer that binds
toGDP-boundG. Upon binding extracellular ligand, such as a
tastant, the GPCR acts as a guanine nucleotide exchange factor,
promoting release of GDP from G (4). Nucleotide-free G
then binds GTP and releases G (5). Both GGTP and freed
G are then capable of modulating downstream effectors (ion
channels, enzymes) specific to each heterotrimer subtype and
cellular context (6–8). Intrinsic GTPase activity of G returns
it to the GDP-bound state, allowing re-formation of the
GGDP/G heterotrimer. This reassociation terminates
effector interactions (9). Thus, the duration of GPCR signaling
is determined by the lifetime of G in the GTP-bound state.
However, the rate of intrinsic GTP hydrolysis by G observed
in vitro rarely accounts for the speed ofGPCR signaling decay in
vivo (9, 10). Several groups (11–14) simultaneously discovered
the “regulators of G protein signaling” (RGS proteins), a super-
family of proteins that dramatically increase the rate of GTP
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hydrolysis by G subunits and thereby determine the duration
of GPCR signaling (15). For example, in the mammalian visual
system controlled by the GPCR rhodopsin, the time constant at
which rod photoreceptor cells recover from flash response
increases from 0.2 s (wild-type) to 9 s in RGS9-deficient mice
(16), clearly highlighting the importance of RGS proteins to
proper signal transduction timing (17).
The T1R and T2R families of GPCRs compose the mamma-
lian taste receptors that detect the taste modalities of umami,
sweet, and bitter (18). The T2R family is responsible for trans-
duction of bitter taste (19, 20). In contrast to the T2R receptors,
which are functional when expressed individually, T1Rs only
function when expressed as heterodimers (21, 22). L-Amino
acids (umami compounds) signal through the T1R1-T1R3 het-
erodimer (22). Similarly, sweet compounds bind to the T1R2-
T1R3 heterodimer to initiate taste signaling (21).
Perception of bitterness by the gustatory system helps to
identify toxic or spoiled foods that should not be ingested; how-
ever,many nonharmful compounds also are perceived as bitter,
including some artificial sweeteners and many medicines (23–
30). Tastant receptors have also been identified outside the gus-
tatory system, including bitter receptors in ciliated epithelial
airway and enteroendocrine cells (31–34), but their function in
these tissues is still being determined. Understanding the phys-
iological regulation of these signaling pathways should lead to
the development of more palatable therapeutics and artificial
sweeteners, as well as better glucose modulators.
The critical components of taste transduction downstream
of the T1R and T2R receptors are slowly being elucidated. Sim-
ilar to the visual system, which has two unique G subunits
specific for rods and cones, lingual taste cells also have a unique
G called gustducin- (encoded by GNAT3), which is highly
related by sequence to rod transducin (Gt-rod, encoded by
GNAT1) (35). Gustducin has a critical role in the transduction
of bitter and sweet taste (36); however, the appetitive effects of
umami compounds are only lost when animals are deficient in
both gustducin- and Gt-rod (37), suggesting some degree of
functional redundancy. Although gustducin and transducin are
widely accepted to be the criticalG subunits inmediating taste
in lingual tissue (36, 37), the role of other G subunits remains
unknown.The ability of gustducin-/transducin double knock-
outmice to still produce recordable action potentials on chorda
tympani recordings upon exposure to bitter tastants (37), and
the high levels of Gi2 expressed in lingual taste cells (38), sug-
gests that Gi2 may also have a role in taste transduction (37,
39).
Although knock-out mice have shown the importance of
gustducin and transducin to gustation signal transduction,
downstream second messenger systems have also been impli-
cated. Tastant-dependent heterotrimer activation is seen to
rapidly change cyclic nucleotide levels (including cAMP) in a
phosphodiesterase-dependentmanner, but a physiological role
of these changes remains unsupported by direct evidence (40).
Tastant receptor activation also results in a PLC-2-mediated
increase in intracellular calcium and subsequent gating of the
taste-transduction channel TRPM5. Both PLC-2-null and
TRPM5-null mouse strains have reduced or a complete loss of
bitter, sweet, and umami signaling (41, 42).
Although multiple intracellular modulators are known to
regulate G protein activity and GPCR-initiated signaling (43,
44), modulators specific to tastant signal transduction are only
now being identified (e.g. Refs. 45 and 46). Two independent
groups identified a novel member of the RGS protein family,
RGS21, that may be involved in tastant signal transduction
based on its expression in lingual taste-responsive epithelium
(47, 48). Using in situ hybridization and RT-PCR, RGS21
expression was identified only in a subset of taste bud cells in
one study (47), yet found in every tissue screened in the other
(48). Neither report established the specific function of RGS21
in tastant signal transduction (47, 48). Thus, our present study
aimed to clarify the discordant reports of RGS21 expression
and define its role in tastant signaling, thereby furthering our
collective understanding of the physiological modulation of
taste perception.
EXPERIMENTAL PROCEDURES
Chemicals and Assay Materials
Unless otherwise noted, all chemicals were the highest grade
available from Sigma or Fisher Scientific (Pittsburgh, PA).
Reverse Transcription-Polymerase Chain Reaction (RT-PCR)
RNA Isolation—Cells from lung epithelial cell lines were
stored in RNase-free PBS at 20 °C for up to 16 h before use.
RNA isolations were performed in an RNA purification tray,
using the ABI Prism 6700 automated nucleic acid work station
(PE Biosystems) and following the manufacturer’s protocol.
Total RNA samples were stored at 20 °C.
Primers and Probes—The nucleotide sequences of the PCR
primers and their fluorogenic probes for the target genes were
designed by using the computer program Primer Express (PE
Biosystems). Each fluorescent probe had a reporter dye (FAM
for the target RNA and TET for the 18 S RNA control) cova-
lently attached at its 5 end and a quencher dye (TAMRA)
attached at its 3 end. Before use, the probes were purified by a
PolyPak II cartridge (Glen Research, Sterling, VA) following the
manufacturer’s instructions.
RT-PCR Amplifications—Real-time RT-PCR amplifications
were performed in a 96-well plate in an ABI Prism 7700
sequence detector (PE Biosystems) in a total volume of 30 l,
which included 10 l of RNA sample from the ABI Prism 6700
plus 20l of a reactionmixturemadewithminormodifications
of themanufacturer’s instructions. Each RT-PCR amplification
was performed in triplicate: 30min at 48 °C for the RT reaction,
then 10 min at 94 °C, followed by a total of 40 temperature
cycles (15 s at 94 °C and 1 min at 60 °C). During the amplifica-
tion, the fluorescence of FAM (or TET), TAMRA, and ROX (a
passive reference dye) was measured by the 7700 Sequence
Detector in each well of the 96-well plate. The cycle numbers at
which the fluorescence of the PCR starting samples crossed a
set threshold (Ct) were calculated by using the sequence detec-
tor software incorporated in the ABI Prism 7700 Sequence
Detector System.
Relative Quantification of Gene Expression—Amplification
of the 18S RNA gene was used as an endogenous control. For
each experimental sample, the relative amounts of the target
and endogenous control were determined from the Ct. We
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assume that 18S RNA is present in all tested samples of cell
RNA at a constant proportion and therefore normalized the
amount of total RNA in our test samples by comparing theCt of
their 18S RNA with that of our test genes. For each gene, the
datawere then expressed as a percentage of the cell linewith the
highest normalized Ct (49).
In Situ Hybridization
cDNA spans from themouse Rgs21 open reading frame (full-
length),PLC2 (nucleotides 227–740), and gustducin- (nucle-
otides 83–610) were separately cloned into pBluescript II SK
(Stratagene) using the KpnI and NotI digestion sites. Digoxige-
nin-labeled riboprobes were generated using T7 RNA polym-
erase and a digoxigenin-RNA labeling mix (Roche Applied Sci-
ence). Hybridization was performed by the University of North
Carolina (UNC) Neuroscience Center In Situ Hybridization
Core according to standard protocols (UNC-Chapel Hill).
Generation of Rgs21::RFP BAC Transgenic Mice
A 232-kilobase bacterial artificial chromosome (BAC) from
mouse chromosome1 (RP23–126D12: nucleotides 146,254,848
to 146,486,740) that encodes TagRFP (50) driven by the Rgs21
promoter was engineered by BAC recombineering and purified
by pulsed field electrophoresis by the UNCNeuroscience Cen-
ter BAC Engineering Core Facility. Pronuclear injections were
performed by the UNC Animal Models Core on C57Bl/
6XDBA2 hybrid embryos, which were subsequently implanted
into pseudo-pregnant recipient females. Resultant pups were
genotyped via tail biopsies at 21 days to confirm gene expres-
sion, andRgs21::RFP BAC-transgenic foundermice were estab-
lished. Rgs21::RFP BAC transgenic mice were bred with wild-
type C57Bl/6J mice and the resulting F1 pups were utilized in
this study. All animal protocols received prior approval by the
Institutional Animal Care and Use Committee (IACUC) of
UNC-Chapel Hill and all animals were cared for in an
AAALAC-accredited vivarium according to NIH standards.
Immunofluorescence
Mouse tongues were removed post-humane euthanasia and
fixed in 4% paraformaldehyde at 4 °C overnight, followed by an
overnight incubation in 30% sucrose at 4 °C. Circumvallate
papillae were then dissected from these fixed tongues, embed-
ded, and frozen in Tissue-Tek OCT compound (Fisher Scien-
tific), and coronally sectioned (12mthick) at22 °C.Circum-
vallate papillae sections were mounted on FisherBrand
SuperfrostPlus slides and permeabilized with 0.5% Triton
X-100 in phosphate-buffered saline (PBS) for 1 h at room tem-
perature. These slides were incubated in blocking buffer (0.5%
Triton X-100 and 1% bovine serum albumin in PBS) for an
additional hour at room temperature and then probed over-
night at 4 °C with rabbit anti-gustducin- polyclonal primary
antibody (sc-395; SantaCruz) diluted in blocking buffer. After 4
washes in PBS, slides were incubated again for 30 min in block-
ing buffer and then probed for 1 h at room temperature with
Alexa Fluor-488 goat anti-rabbit IgG (heavy and light chains)
secondary antibody (Invitrogen) diluted in blocking buffer.
Slides were then washed 4 times in PBS. Vectashield mounting
medium with DAPI (Vector Labs) was applied to mount glass
coverslips onto the slides. Immunofluorescence was detected
with an IX70 epifluorescence microscope (Olympus) and
mounted digital camera (Hamamatsu). Images were digitally
processed and pseudocolored using Adobe Illustrator CS4
software.
Cloning
The RGS21 open reading frame (ORF) was cloned by PCR
from cDNA isolated from rat taste bud cell (a gift fromDr. Lars
von Buchholtz, NIH/NIDCR) using the sense primer,
5-CCAGTGAAATGCTGTTTCTAC-3 and antisense primer,
5-CAGGAAAGGCAGCCATC-3 with an annealing temper-
ature of 52 °C and an extension time of 22 s using Phusion
thermostable DNA polymerase (New England Biolabs, Ips-
wich, MA). Following amplification, a 453-bp band was
resolved using agarose electrophoresis and isolated by Qia-
gen Gel Extraction (Qiagen). A second round of PCR, using
primers to extend the RGS21 ORF sequence, was used to
subclone the isolated fragment into a pET-based (Novagen)
ligation-independent cloning vector to make a tobacco etch
virus protease-cleavable His6 fusion protein for expression
in Escherichia coli, as well as into a pcDNA3.1-based (Invit-
rogen) ligation-independent cloning vector to make a
hemagglutinin (HA)-epitope fusion protein for expression in
mammalian cells, both as previously described (51, 52).
QuikChange site-directed mutagenesis (Stratagene) was
used to mutate Arg-126 of the RGS21 ORF to a glutamic acid
codon (R126E) with sense primer, 5-gtctcatggccaaggattccttccct-
gagtttctaaagtcagaaatttataagaaa-3 and antisense primer,
5-tttcttataaatttctgactttagaaactcagggaaggaatccttggccatgagac-3.
Protein Expression and Purification
The pET-based vector encoding the His6-rRGS21(wild type)
or -RGS21(R126E) ORF was transformed into E. coli
BL21(DE3) cells (Novagen) and grown at 37 °C in Luria broth
until a culture density of A600  0.75 was reached. Protein
expression was then induced by addition of 0.75 mM isopropyl
-D-thiogalactopyranoside. After culture for 14–16 h at 20 °C,
cells were pelleted by centrifugation and frozen at80 °C. Prior
to purification, bacterial cell pellets were resuspended in N1
buffer (50 mMTris, pH 7.5, 300 mMNaCl, 30 mM imidazole, 5%
(w/v) glycerol) for lysis using high-pressure homogenization
with an Emulsiflex (Avestin, Ottawa, Canada). Cellular lysates
were clarified by centrifugation for 45min at 100,000 g at 4 °C
before the supernatant was applied to a nickel-nitrilotriacetic
acid resin FPLC column (FF HisTrap; GEHealthcare). The col-
umn was washed with 7 column volumes of N1 lacking imidaz-
ole, then 3 column volumes of N1 containing 30mM imidazole,
5 column volumes of N1 containing 300 mM imidazole, and 5
column volumes of N1 containing 700 mM imidazole. Soluble
RGS21 protein was found in the 300 mM imidazole-containing
fractions. The column flow-through was pooled and resolved
using a calibrated 150-ml size exclusion column (Sephacryl
S200, GEHealthcare) with S200 buffer (50mMTris, pH 7.5, 150
mM NaCl, 5% (w/v) glycerol). Protein was concentrated to 1
mM as determined by A280 nm measurements upon denatur-
ation in guanidine hydrochloride. Circular dichroism spectra
were separately collected using 0.1 mg/ml of RGS21 and
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RGS21(R126E) proteins, each diluted in 10 mM potassium
phosphate salt, pH 7.5, at 25 °C using a PiStar-180 spectropho-
tometer (Applied Photophysics, UK) within the University of
North Carolina Macromolecular Interactions Facility (Dr. Ash
Tripathy, director). Spectra were collected from 185 to 260 nm
in 0.5-nm steps with a bandwidth of 2 nm.
His6-GoA was purified using a similar chromatographic
methods as previously described (53). His6-Gi1,i2,i3 and His6-
Gi1(G183S) subunits were purified exactly as previously
described for the production of Gi1 (54). The His6-Gt/i1 chi-
meric G subunit (“Chi6”) was purified as previously described
(55) and G-transducin was purified from bovine rod outer
segments as previously described (56).
Cell Culture and Co-immunoprecipitation
COS-7 cells and the human bronchial airway epithelial cell
line 16HBE were separately cultured in Dulbecco’s modified
Eagle’s medium (Invitrogen) supplemented with 10% fetal
bovine serum (Denville Scientific, Metuchen, NJ) and penicil-
lin-streptomycin (Mediatech, Inc., Manassas, VA) and main-
tained at 37 °C in a humidified atmosphere containing 5% CO2.
COS7 cells were plated in 6-well dishes and transfectedwith 1.5
g of DNA (when at 70% confluence) with LipofectamineTM
2000 (Invitrogen) according to themanufacturer’s instructions.
Cells were lysed in lysis buffer containing 20 mM Tris (pH 7.5),
100 mMNaCl, 100 MGDP, 5 mMMgCl2, 1 mM EGTA, and 1%
Triton X-100. To mimic the GTP hydrolysis transition state of
the heterotrimericG-protein subunit, lysis buffer was supple-
mented with 20 mM NaF and 30 M AlCl3. Cell monolayers
were scraped in lysis buffer and incubated at 4 °C for 45 min
with sonication before insoluble componentswere separated by
centrifugation at 14,000  g at 4 °C for 10 min. Recombinant
purified His6-RGS21 protein (10 g) was then added to the
clarified cell lysate and rocked at 4 °C for 1 h before addition of
NTA-agarose and continued incubation overnight at 4 °C
with rocking. NTA-agarose was then washed four times with
lysis buffer and bound proteins were resolved using SDS-
PAGE electrophoresis, transferred to nitrocellulose, and
detected by chemiluminescence using standard immuno-
blotting techniques.
Surface Plasmon Resonance (SPR) Assay
Optical detection of protein-protein interactions using SPR
was performed using the Biacore 3000 (GE Healthcare) of Uni-
versity of North Carolina Center for Structure Biology exactly
as previously described (57, 58).
Single-turnover GTPase Assay
The intrinsic and RGS protein-enhanced GTP hydrolysis
rates of G subunits were assessed by monitoring the produc-
tion of 32Pi (inorganic phosphate) during a single round of
[-32P]GTP hydrolysis, as previously described (59). In brief,
purified G subunits (100 nM) were separately incubated for 10
min at 20 °Cwith 1 106 cpmof [-32P]GTP (PerkinElmer Life
Science; specific activity of 6500 dpm/Ci) in reaction buffer
lackingMg2 (50mMTris, pH 7.5, 0.05% (v/v) polyoxyethylene
10 laurel ether (C12E10), 1 mM DTT, 10 mM EDTA, 100 mM
NaCl, and 5g/ml of BSA). The reactionwas then chilled on ice
for 5 min prior to initiation of the reaction by the addition of
RGS protein, 10 mM MgCl2, and 100 M GTPS (final concen-
tration). At periodic intervals, 100-l aliquots were quenched
in 900 l of charcoal slurry (i.e. 5% (w/v) activated charcoal in
50 mM H3PO4, pH 3.0) and centrifuged at 4 °C for 10 min at
3000  g. Subsequently, 600-l aliquots of the supernatant
were counted via liquid scintillation to quantify 32Pi produc-
tion. Protocol modifications for quantifying GTPase activity
from transducin were made as previously described (60).
Ex Vivo Tracheal Epithelial Cultures
Mouse tracheal epithelia (MTE) were obtained from
Rgs21::RFP transgenic mice and aged-matched, wild-type
C57Bl/6J mice by enzymatic digestion as previously described
(61) under a protocol approved by theUNC IACUC.MTEwere
maintained at an air-liquid interface in a modified bronchial
epithelial growth medium with 5% CO2 at 37 °C and used 2–5
weeks after seeding on 12-mm T-clear inserts (Corning-Co-
star). To label the airway surface liquid, PBS containing 10-kDa
FITC/dextran (0.2 mg/ml; Sigma) was added to MTE mucosal
surfaces and then liveMTE cultures were imaged by XZ confo-
cal microscopy as previously described (62). Briefly, a 63X glyc-
erol immersion objective was used; the airway surface liquid
was imaged using a 488 nmargon laser andTagRFP proteinwas
imaged using a 561 nm diode-pumped solid-state laser.
Stable shRNA-mediated Knockdown of Endogenous RGS21
Expression
Stable 16HBE cell lines with reduced RGS21 expression were
generated via lentiviral infection. pLKO.1 plasmids encoding
human RGS21-directed shRNA (Oligo IDs TRCN0000036859,
TRCN0000036861, and TRCN0000036863; generated by The
RNAi Consortium and purchased from Open Biosystems as
catalogue number RHS3979–9604267, RHS3979–98492449,
and RHS3979–9604271) were prepared from bacterial stocks
via maxiprep (Qiagen; Valencia, CA) and packaged into lentivi-
ral stocks by the UNC Lineberger Comprehensive Cancer Cen-
ter Lenti-shRNA Core Facility (Dr. Tal Kafri, director). A con-
trol empty lentiviral vector (Open Biosystems catalogue
number RHS4080) was also packaged to establish the negative
control cell line. These viruses were used to infect separate
16HBE cell cultures seeded onto 100-mmdishes at 50% conflu-
ence. Stably transfected cell lines were selectedwith puromycin
(Cellgro, Manassas, VA) and maintained in standard medium
supplemented with puromycin for several weeks prior to use in
second messenger assays.
siRNA Knockdown in 16HBE Cells
All siRNA used in this study were chemically synthesized by
Dharmacon RNAi Technologies and purchased as an siG-
ENOME set consisting of four individual siRNA oligonucleo-
tide duplexes directed toward human RGS21. 16HBE cells
seeded in 6-well plates were co-transfected with a pool of all
four RGS21-directed siRNA oligonucleotide duplexes (100 nM)
with Lipofectamine 2000 (Invitrogen) using themanufacturer’s
protocol. A control siRNA (siGlo Lamin A/C) was separately
transfected to visualize transfection efficiency and act as a neg-
ative control. After 24 h, cells were seeded onto poly-D-lysine-
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coated 96-well plates. Approximately 18–24 h after seeding,
fluorescence imaging plate reader (FLIPR) assays for bitterant-
induced calcium flux were performed as described above.
Knockdown of the RGS21 transcript was confirmed 48 h post-
transfection via qRT-PCR.
FLIPR Calcium Flux Assays
Calcium flux assays were performed using the FLIPRTETRA
(Molecular Devices, Sunnyvale, CA) of theNIMHPsychoactive
Drug Screening Program located at UNC (PDSP; Dr. Bryan
Roth, director) as previously described (63). 16HBE cells were
trypsinized, counted, and seeded onto clear-bottom 96-well
plates (Greiner Bio-One,Monroe, NC) pre-coated with poly-D-
lysine, at a density of 7.5  104 cells per well. After a 24-h
incubation, media was removed and replaced with a no-wash
dye (FLIPR Calcium Assay Kit; Molecular Device Corp.,
Sunnyvale, CA). After a 1-h incubation at 37 °C, during which
the cells were allowed to take up the dye, fluorescence
responses of cells were measured with the FLIPRTETRA device
upon the addition of variable concentrations of tastant, or vehi-
cle, in the presence of assay buffer (20 mM HEPES, pH 7.4, 1
Hanks’ balanced salt solution (Invitrogen), and 2.5 mM probe-
necid). After 500 s of data acquisition, a subsequent addition of
5 M thapsigargin or 3 M KCl was injected into each well, and
fluorescence was measured again. Net peak responses to tas-
tants were normalized to net peak responses to thapsigargin/
KCl. Responses were compared with that of wild-type control
16HBE cells. Statistical and graphical analyses were performed
using Prism version 5.0b (GraphPad Software, La Jolla, CA).
cAMP Accumulation GloSensor Assay
16HBE cell cultures were transiently co-transfected with
the GloSensor cAMP-biosensor cDNA (Promega) and
pcDNA3.1-based expression plasmids as previously described
(64). Twenty-four hours post-transfection, cells were re-plated
on poly-D-lysine-treated, clear-bottom, white 384-well plates at
a density of 15,000 cells/well. Forty-eight hours post-transfec-
tion, culturemediumwas aspirated and cells were washed once
with assay medium (DMEM (without FBS or phenol), 15 mM
HEPES, pH 7.4) before being incubated for 2 h with 20 l/well
of equilibration medium (assay medium with 4% GloSensorTM
substrate (Promega)). After 2 h, 10 l of 3 final concentration
of denatonium benzoate (diluted in 3 mM forskolin-containing
assay medium) was added to each well and allowed to incu-
bate for 10 min before GloSensor emission was read on a
MicroBeta Plate Counter (PerkinElmer). Before plotting,
luminescence counts were normalized to 100% maximal
response for each condition to account for variability in
GloSensor expression, transfection efficiency, and the exact
number of cells per well.
RESULTS AND DISCUSSION
RGS21 Is Expressed Outside of the Lingual Gustatory System—
Given the discrepancy in expression patterns presented by the
first two reports on RGS21 (47, 48), we profiled the expression
of Rgs21 transcripts by quantitative reverse transcription-PCR
(qRT-PCR) on RNA isolated from various human as well as
mouse tissues. In human tissues, RGS21 was found highly
expressed in circumvallate papillae and expressed at a lower
level in lung tissue (Fig. 1A). This same pattern was also
observed in mouse tissue, with the addition that Rgs21was also
detected in RNA isolated from whole, homogenized mouse
tongue (Fig. 1C). These results are consistent with the expres-
sion pattern of rat Rgs21 originally described by von Buchholtz
et al. (47). To identify more specifically the cellular distribution
of mouse Rgs21 expression within the lingual tissue, in situ
hybridization was performed on sections of the mouse tongue.
Using this approach, mouse Rgs21 was detected in taste bud
cells in the circumvallate papillae, with an expression pattern
similar to those of gustducin- and PLC2 transcripts (Fig. 1,
E–G).
Given recent evidence suggesting that gustation signaling
components are expressed in enteroendocrine cells of the
digestive tract (31, 32), we also analyzedRGS21 transcript levels
in different regions of the human and mouse gastrointestinal
tract. Although RGS21 transcripts were identified in various
regions of the human gastrointestinal tract (Fig. 1B), Rgs21
expression was not detectable in the mouse gastrointestinal
tract (Fig. 1D). Although this may represent a difference in
expression between the two organisms, it may also be the result
of differential probe sensitivity; however, our results do suggest
thatRGS21 expression is associatedwith tastant signaling com-
ponents known to be expressed in gustatory cells of the human
digestive tract (31, 32).
To explore further the expression pattern of themouseRgs21
gene locus, a bacterial artificial chromosome (BAC) transgenic
mouse strainwas established that expresses TagRFP (50) driven
by the Rgs21 promoter. Consistent with the qRT-PCR data of
Fig. 1C and in situhybridization data of Fig. 1G, TagRFPprotein
was expressed in the taste buds of the circumvallate papillae
(Fig. 2). In combining epifluorescence with immunofluores-
cence, TagRFP expression was found to be co-localized with
gustducin -subunit expression within taste bud cells (Fig. 2,
A–D). To confirm the qRT-PCR data indicating RGS21 expres-
sion in lung tissue, we cultured MTE cells from Rgs21::RFP
transgenic mice at an air-liquid interface for 3 weeks; XZ con-
focal scanning revealed that TagRFP fluorescence was clearly
detectable inMTEcells of transgenicmouse cultures, but unde-
tectable in control mice (Fig. 2, I–K).
RGS21 Is Predicted to be a Highly Active, and Promiscuous,
G-directed GAP—RGS21 belongs to the R4 family (9) of RGS
proteins that are generally composed of little more than a cen-
tral, 130 amino acid RGS domain; indeed, at 152 amino acids
long, RGS21 is mainly an RGS domain with short N- and C-ter-
minal extensions. Some of us (65) recently described applying
electrostatic calculations of interaction energies across multi-
ple, high-resolution G/RGS protein structures (e.g. Refs. 66
and 67) to predict RGS domain residues essential for high-level
GAP function and G substrate selectivity. Applying this ener-
gy-based, residue-level analysis to RGS21 (Fig. 3A) revealed
that this RGS protein has the full complement of “significant
and conserved” residues critical for the GAP activity of such
highly active RGS proteins as RGS4 and RGS16. RGS21 also has
eight “functionalmodulatory” residues (Fig. 3A), which is at the
high end of the range (six to eight) observed in high activity RGS
domains (65). Importantly, all of the RGS21 residues in modu-
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latory positions that are different from those in high activity
RGS domains (four positions; Fig. 3A) were predicted not to
interfere with canonical G recognition. Therefore, RGS21was
predicted to be a highly active and promiscuous G-directed
GAP, similar to the high activity RGS domains that share the
aforementioned structural properties (e.g. RGS4 and RGS16;
Ref. 65).
RGS21 Interacts with Multiple G Subunits—Although
R4-family RGS proteins, like RGS4 and RGS16, primarily bind
to adenylyl cyclase inhibitory (Gi/o) and Gq/11 subunits (66–
68), RGS proteins in general have also been reported to modu-
late signaling mediated through Gs (69, 70), Golf (71), and
G12/13 (6, 72, 73) subunits. To identify the subset of G pro-
teins that are capable of interacting with RGS21, pulldown
assays were performed with recombinant His6-RGS21 protein
and cellular lysates containing overexpressed G subunits.
RGS21 was observed to bind Gi1, Gq, rod and cone transdu-
cin- (GNAT1 and GNAT2 gene products) and gustducin-
(GNAT3) in their transition state forms (e.g. bound with
GDP/AlF4) and not in their ground state, GDP-bound forms
(Fig. 3B). These results with RGS21 are consistent with other
reports that, with the exception of RGS2 (64, 74), all R4-fam-
ily RGS domains can interact with both adenylyl cyclase
inhibitory (Gi/o) and PLC stimulatory (Gq) G subunits (66,
75).
The primary G subunits implicated in gustation are gust-
ducin- and transducin- (36–38). Based on the RGS9/trans-
ducin- structure and its comparison to other RGS domain-G
complexes (66, 76), the predicted RGS domain contact residues
within gustducin- are 95% identical and 100% similar to those
of transducin- (Fig. 3C). Given this degree of similarity, we
expect that RGS21 acts equivalently on both transducin and
gustducin- subunits (the latter being far more difficult to
obtain in purified form than transducin).
FIGURE 1. RGS21 transcripts are highly expressed in lingual gustatory epithelium as well as in lung and human gastrointestinal tissues. A and B,
real-time, quantitative RT-PCR using fluorogenic probe detection was performed on total RNA from indicated human organs. Variable quantities of RNA were
normalized by comparison to 18S ribosomal RNA and RGS21 expression in the circumvallate (c.v.) papillae was set to “100% relative expression” using the
2(Ct) method (49). C and D, total RNA was extracted from the indicated mouse organs prior to quantitative RT-PCR analysis. Variation in total amounts of RNA
isolated from each organ was normalized by comparison to 18S ribosomal RNA and RGS21 expression in the whole tongue preparation was set to “100%
relative expression” using the 2(Ct) method (49). E--G, coronal sections of mouse c.v. papillae were hybridized with digoxigenin riboprobes for PLC2 (E),
gustducin- (aka GNAT3) (F), and Rgs21 (G). Following hybridization and washes, probes were detected using an alkaline phosphatase-conjugated anti-
digoxigenin antibody and 5-bromo-4-chloro-3-indolyl phosphate/nitro blue tetrazolium chromogenic development. Taste buds within stratified squamous
epithelium along the left side of the depicted central c.v. papilla are outlined in yellow; examples of probe staining are indicated with arrowheads.
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SPR spectroscopy was used to determine whether the
RGS21/G interaction is direct and occurs in amanner consist-
ent with the canonical RGS domain/G interaction (66, 67). An
SPR biosensor surface was generated with either immobilized
biotin-Gi1 or His6-Gq fusion protein, and RGS21 was subse-
quently injected over each surface, either in buffer containing
aluminum tetrafluoride (to create the transition state form) or
GDP alone. RGS21 bound selectively to Gi1(GDP/AlF4) and
Gq(GDP/AlF4) with dissociation constants (Kd values) of 64
nM (95% confidence interval (CI) of 40–87 nM) and 20 nM (95%
CI 11–29 nM), respectively (Fig. 4, A and B). These affinities for
transition state G subunits are consistent with earlier reports
fromotherR4-family RGSproteins obtainedusing SPR (77).No
binding was observed to either Gi1 or Gq surfaces when in
their GDP-bound ground state. A charge reversal of the highly
conserved Arg-126 (highlighted in Fig. 3A) to glutamic acid
(R126E), previously shown to disrupt other RGS domain/G
interactions (53, 64), was observed to disrupt the RGS21 inter-
action with Gi1(GDP/AlF4) and Gq(GDP/AlF4) surfaces.
Circular dichroism studies were performed to verify that the
global-fold of the mutant protein was preserved (Fig. 4D).
To verify the affinities observed with immobilized G bio-
sensor surfaces, and to test additional purified G subunits for
their interaction with RGS21, the SPR experimental setup was
inverted (Fig. 4C) with a GST-RGS21 fusion protein biosensor
surface being generated (57). Binding affinities (KD values) for
the interaction between GST-RGS21 and the GDP/AlF4-
bound, transition state forms of Gi1, Gi2, Gi3, Go, and
transducin- (Chi6 chimer; Ref. (55)were determined to be 114
(95% CI 65–163 nM), 63 (30–95 nM), 61 (25–97 nM), 24 (18–32
nM), and 190 nM (134–247 nM), respectively; as previously
observed (Fig. 4B), no binding was detected to GDP-bound G
subunits (Fig. 4C).
RGS21 Is a Potent GAP for Multiple G Subunits in Vitro—
To assess directly if RGS21 accelerates the GTPase activity of
GTP-bound G subunits, RGS domain-mediated GAP activity
FIGURE 2. The Rgs21 gene promoter is active in taste bud cells co-incident with gustducin- expression, as well as in tracheal epithelium. A–G, sections
of mouse circumvallate papillae from Rgs21::RFP transgenic (Tg) and wild-type (Wt) mice were stained with anti-gustducin- antibody and then imaged by
epifluorescence to detect the expression pattern of gustducin- (green; panels A and B) and TagRFP protein expressed from the Rgs21 promoter (red; panels C
and D). Images were merged, with co-localization of gustducin- and RFP signals pseudocolored yellow (panels E and F) and additionally with phase-contrast
and DNA staining (DAPI) colored gray and blue, respectively (panels G and H). I–L, explanted tracheal epithelium from Rgs21::RFP transgenic and wild-type mice
was cultured ex vivo in an air-liquid interface for 3 weeks and then imaged for TagRFP protein expression by confocal microscopy (panels I–J) and for cellular
morphology by bright-field microscopy (panels K–L). Air-liquid interface was highlighted by the addition of FITC-dextran to the airway surface liquid. Images
presented are representative of n  6 Rgs21::RFP transgenic and n  6 wild-type mice were analyzed.
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was measured using a single round of [-32P]GTP hydrolysis,
commonly referred to as “single turnover” assays (59, 78).
RGS21 robustly accelerated the hydrolysis of GTP by Gi1 (Fig.
5A): the intrinsic GTPase rate by 100 nM Gi1 was determined
to be 0.009 s1 (95% CI 0.007–0.011 s1), whereas the GTPase
rate upon addition of a substoichiometric amount of RGS21 (50
nM) was 0.25 s1 (95% CI 0.11–0.38 s1), over 25 times faster.
RGS21-mediated GAP activity was also observed using recom-
binant Gi2, Gi3, and Go, as well as transducin- purified
from bovine rod outer segments (Fig. 5, C–F; summarized in
Table 1).
To ensure that these observed hydrolysis rate increases were
not due to contaminating GTPase(s) in the RGS21 protein
preparation, single turnover assays were repeated with a RGS-
insensitive Gi1 point mutant, Gi1(G183S) (79). The intrinsic
hydrolysis rate of Gi1(G183S) was not accelerated upon the
addition of 250 nM of either wild-type RGS21 or RGS21(R126E)
proteins (Fig. 5B).
FIGURE 3. Prediction and empirical examination of the G substrate promiscuity of RGS21. A, multiple sequence alignment of the minimal RGS domain
region of R4-family RGS proteins, highlighting regions of known -helical secondary structure (overlined) and specific locations of significant and conserved
and putative modulatory residue positions, as defined in Kosloff et al. (65). RGS21 residue arginine 126 is highlighted with an open-star symbol; this residue is
known to be a highly conserved, surface-exposed constituent of the G-binding “A-site” of RGS domains. B, COS7 cells were transiently transfected with
expression vectors for the indicated G subunits and, 48 h later, lysed in buffer containing GDP, Mg2, and AlF4
 () or GDP only (). Clarified cell lysates were
incubated overnight at 4 °C with recombinant His6-RGS21 protein and nickel-nitrilotriacetic acid-agarose beads (PD, pulldown), prior to detection of co-pre-
cipitated, HA-tagged G subunit by SDS-PAGE, electrotransfer to nitrocellulose, and immunoblotting (IB) with anti-HA antibody and chemiluminescence
detection. C, gustducin and transducin G subunits have nearly identical interfaces for RGS domains. A protein sequence alignment of human gustducin-
(GNAT3, GenBank accession number NP_001095856.1), transducin- (GNAT1, GenBank NP_653082.1), and Gi1 (GNAi1, GenBank NP_002060.4) was
generated using ClustalW. Contacts between the Ras-like domain of transducin- (Chain A) and the RGS9 RGS domain (Chain B) from the RGS9/
transducin- structure (PDB code 1FQK; Ref. 76) were identified using contact map analysis (83) and are denoted with a C above the alignment. Sw,
switch region.
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RGS21 Overexpression Blunts Bitter Tastant Responsiveness
of a Human Lung Airway Epithelial Cell Line—To determine
whether RGS21 is capable of modulating gustatory signaling in
an integrated, whole cell context, we first used RT-PCR to iden-
tify a model cell line expressing components of the gustatory
signaling cascade as well as endogenous RGS21. The trans-
formed human bronchial epithelial cell line 16HBE (80) was
found to expressmRNA transcripts forRGS21, multiple tastant
FIGURE 4. RGS21 interacts with transition-state forms of Gq and Gi/o subunits with nanomolar affinities. A, biotin-Gi1 and alkaline-denatured
biotin-Gi1 were immobilized on separate streptavidin biosensor surfaces for SPR binding analyses. Indicated concentrations of recombinant RGS21 protein
were injected over both surfaces at 20 l/min for 600 s (injection start at t  0) with a subsequent 300-s dissociation time. Nonspecific binding to the
alkaline-denatured biotin-Gi1 surface was subtracted using BiaEvaluation software. B, sensorgrams derived from experiments as illustrated in panel A were
used for equilibrium saturation binding analyses to determine the affinity of wild-type RGS21 or RGS21(R126E) proteins for Gi1 or Gq in both their transition
state (GDP/AlF4
) and ground state forms. Gq biosensor sensorgrams were obtained by immobilizing His6-Gq using capture coupling. Dissociation constants
(KD values) for the Gi1(GDP/AlF4
)/RGS21 and Gq(GDP/AlF4
)/RGS21 interactions were determined to be 64 (95% CI 40 – 87 nM) and 20 nM (95% CI 11–29 nM),
respectively. No specific binding was observed for the loss-of-function RGS21(R126E) protein toward Gi1 or Gq nor for wild-type RGS21 toward GDP-bound
Gi1 or Gq. C, GST-RGS21 fusion protein or GST alone was immobilized on an anti-GST antibody biosensor surface. 200 l of the indicated concentrations of
various G subunits (in their transition state form) were injected over the biosensor surface. Nonspecific binding toward GST alone was subtracted using
BiaEvaluation. The binding at t  590 s was plotted and used for equilibrium binding analyses. The affinities of Gi1, Gi2, Gi3, Go, and transducin- for
immobilized RGS21 were determined to be 114 (95% CI 65–163 nM), 63 (30 –95 nM), 61 (25–97 nM), 24 (18 –32 nM), and 190 nM (134 –247 nM), respectively. Open
symbols denote no binding was detected when the various G subunits were in their ground state, GDP-loaded form. D, wild-type RGS21 and RGS21(R126E)
proteins were observed to have similar overall secondary structure by circular dichroism analysis. Circular dichroism spectra were separately collected using 0.1
mg/ml of RGS21 and RGS21(R126E) proteins. Spectra were collected from 185 to 260 nm in 0.5-nm steps with a bandwidth of 2 nm. Inset, RGS21 proteins used
in these biochemical analyses were equivalently purified from E. coli fermentation, as highlighted by Coomassie Blue staining after being resolved by
SDS-PAGE.
FIGURE 5. RGS21 acts as a GAP for Gi/o subfamily G subunits. Intrinsic GTPase activity of the indicated G subunits, as well as RGS protein acceleration of
this activity, was determined using [-32P]GTP single turnover assays. In the absence of Mg2, 100 nM Gi1 (A), RGS-insensitive Gi1(G183S) (B), Gi2 (C), Gi3 (D),
and GoA (E) were preincubated with [-
32P]GTP at 30 °C for 10 min. The reaction was then initiated by the addition of MgCl2 (10 mM), the indicated concen-
trations of recombinant RGS protein, and cold GTPS (400 M). At the indicated time points, the production of inorganic phosphate was quantified by activated
charcoal filtration and subsequent liquid scintillation. F, assays of transducin GTPase activity were conducted on a preformed complex between the G-protein
heterotrimer (transducin-; 2 M) and the photoreceptor rhodopsin (20 M) and were initiated by addition of [-32P]GTP supplemented with GTP (250 nM).
Nonlinear regression was used to fit the data to a single exponential function; observed rates are presented in Table 1.
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receptors (e.g. the bitter tastant receptors T2R38 and T2R46),
and downstream components of the tastant signaling pathway
(Fig. 6A).
Bitter tastant signaling is known to rapidly reduce cellular cyclic
nucleotide levels (40). To test the hypothesis that RGS21 can serve
as a negative regulator of bitter tastant signal transduction, the
bitter receptor agonist denatonium benzoate (“denatonium-B”)
wasapplied to16HBEcells andtheresultantcAMPdecreaseswere
monitored in the context of artificially heightened cAMP levels
(i.e. forskolin-mediated activation of endogenous adenylyl cycla-
ses). In a concentration-dependent fashion (Fig. 6B), denato-
nium-B application reduced forskolin-mediated cAMP produc-
tion, as predicted (40); overexpressionofwild-typeRGS21, butnot
the GAP-dead RGS21(R126E) mutant, significantly blunted the
bitter tastant-induced reduction in cAMP production. To ensure
that RGS21 overexpression did not have unanticipated, global
consequences on GPCR-mediated signaling, isoproterenol-acti-
vated production of cAMP (via -adrenergic receptor activation)
was also monitored in 16HBE cells overexpressing wild-type
RGS21, RGS21(R126E), or vector alone. No significant alteration
in the potency (EC50 values) of isoproterenol uponRGS21 overex-
pression was observed (Fig. 6D).
FIGURE 6. Overexpression of wild-type RGS21, but not a loss-of-function, point mutant, leads to reduction of bitter tastant signaling. A, real-time
qRT-PCR using fluorogenic probe detection was performed on total RNA from the human bronchial epithelium cell line 16HBE to detect the indicated gene
transcripts; data were normalized to levels of 18S rRNA detection. B, 16HBE cell cultures were transiently co-transfected with the Promega GloSensor cAMP-
biosensor cDNA and expression plasmids containing HA epitope-tagged open reading frames for wild-type (wt) rat RGS21, or Arg-126 to Glu point mutated
(Arg3 Glu) rat RGS21, or empty pcDNA3.1 vector, as indicated. Inhibition of forskolin (FSK) stimulated cAMP production by treatment with the indicated
concentrations of denatonium-B was determined 24 h post-transfection by detection of GloSensor-dependent luminescence. Inset, Western blot of whole cell
lysates from transfected 16HBE cultures with anti-HA-epitope antibody and chemiluminescence detection, demonstrating equivalent expression of wild-type
and point mutant RGS21 proteins. Asterisks denote statistically significant differences from signal obtained upon empty vector expression: *, p  0.05; **, p 
0.01 (one-way analysis of variance with Bonferroni’s post-test). C, 16HBE cell cultures were transiently transfected with expression plasmids containing
wild-type (wt) RGS21, or point mutated (Arg3 Glu) RGS21, or empty vector, as indicated. Net peak intracellular calcium production, as elicited by treatment
with the indicated concentrations of denatonium-B was determined using calcium indicator dye and fluorometric imaging plate reader (FLIPR) detection
(relative fluorescence units, RFU), 48 h post-transfection. D, isoproterenol-stimulated production of cAMP is not perturbed by overexpression of RGS21 or
RGS21(R126E) in 16HBE cells. Cells were transfected exactly as described in panel B. Isoproterenol-induced cAMP production was detected by GloSensor-de-
pendent luminescence. EC50 values for isoproterenol were found to be 2.9 (95% CI 2.3–3.7 nM), 3.8 (3.1– 4.7 nM), and 3.8 nM (3.1– 4.7 nM) for 16HBE cells
overexpressing wild-type RGS21, RGS21(R126E), and empty vector, respectively.
TABLE 1
Concentration dependence of RGS21-mediated acceleration of G GTP hydrolysis rates as observed in single turnover assays
Rates were determined using nonlinear regression of data obtained at 4 °C (Fig. 5) using Prism 5.0 and are expressed in s1. 95% confidence intervals are shown in
parentheses. The empty cell indicates that the rate was not determined.
RGS21
(nM) Gi1 Gi1 (G183S) Gi2 Gi3 Go Transducin-
0 0.0090 (0.0071–0.011) 0.0039 (0.0036–0.0042) 0.0074 (0.0058–0.0091) 0.0088 (0.0079–0.0097) 0.00082 (0.00052–0.0011) 0.036 (0.020–0.051)
1 0.015 (0.013–0.018) 0.0092 (0.0081–0.010) 0.013 (0.010–0.016) 0.0092 (0.0083–0.010)
10 0.060 (0.051–0.068) 0.031 (0.028–0.034) 0.033 (0.030–0.036) 0.039 (0.037–0.042)
25 0.051 (0.034–0.067)
50 0.25 (0.11–0.38) 0.20 (0.14–0.25) 0.14 (0.10–0.17) NCa
100 0.23 (0.078–0.38) 0.22 (0.065–0.37) 0.16 (0.12–0.19) NC 0.18 (0.12–0.23)
250 0.0033 (0.0029–0.0036) 0.51 (0.35–0.67)
250; R126E 0.0090 (0.0071–0.011) 0.0033 (0.0029–0.0037) 0.0065 (0.0048–0.0082) 0.0093 (0.0084–0.010) 0.0014 (0.0012–0.0017)
1000 0.74 (0.25–1.2)
1000; R126E 0.033 (0.013–0.053)
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In tastant receptor signal transduction, the releasedGhet-
erodimer is thought to play a key role in intracellular signaling
via PLC-2 activation (18, 42), which results in production of
IP3 and DAG second messengers and a subsequent increase in
intracellular calcium (81). To determine whether RGS21 is also
able to inhibit tastant-mediated activation of Ca2 release, we
monitored intracellular calcium in 16HBE cells upon denato-
nium-B treatment. A decrease in the intracellular Ca2 flux
caused by treatment with denatonium-B was observed in
RGS21-overexpressing 16HBE cells, as compared with cells
overexpressing the GAP-dead RGS21(R126E) mutant or trans-
fected with empty vector only (Fig. 6C).
Knockdown of Endogenous RGS21Expression Enhances Bitter
Tastant Responsiveness—Although both cAMP accumulation
and Ca2 mobilization data suggest that RGS21 can act as a
negative regulator of bitter tastant signaling upon its ectopic
overexpression, we also wanted to test whether endogenous
RGS21 expression serves to negatively regulate denatonium-B
signaling. Three stable 16HBE cell lines were generated with
decreased RGS21 expression using lentiviral shRNA-mediated
knockdown (Fig. 7A). No difference was seen in levels of fors-
kolin-stimulated cAMP production in the absence of denato-
nium-B; however, upon denatonium-B treatment, significant
decreases in cAMP generation were observed in all three cell
lines with reduced RGS21 expression versus the control lentivi-
rus-treated cell line (Fig. 7B). To confirm that stable RGS21
knockdown had not disrupted GPCR-mediated cAMP signal-
ing in a nonspecific fashion, isoproterenol responses were also
tested in these cell lines. No significant different in potency or
maximal efficacy of isoproterenol was observed (Fig. 7D). Intra-
cellular Ca2 flux responses were also measured in the stable
shRNA-mediated knockdown cell lines upon denatonium-B
addition. At both agonist concentrations tested, decreased
RGS21 expression resulted in an increase in denatonium-B-
induced intracellular Ca2 accumulation (Fig. 7C). Increased
calcium flux upon denatonium-B treatment was also observed
upon siRNA-mediated knockdown of RGS21 expression (Fig.
7E).
Conclusions—RGS21 is capable of interacting with, and serv-
ing as aGAP for, multiple G protein subunits, including those
thought to be involved in gustatory signal transduction. RGS21
is endogenously expressed in human and mouse lingual and
airway epithelia and human intestinal tissues. The observed
tissue expression pattern of RGS21 lies between those reported
in two previous studies (47, 48): whereas RGS21 is clearly
expressed in lingual taste bud cells (47), it is also expressed in
other tissues with gustatory epithelia. Interestingly, all of these
tissues additionally express tastant receptors and other, down-
FIGURE 7. RNA interference-mediated knockdown of endogenous RGS21 potentiates bitter tastant signaling. A, quantitative RT-PCR demonstrating
shRNA-mediated knockdown of RGS21 transcript levels in stable, lentivirus-transfected variants of the human bronchial epithelial cell line 16HBE. Real-time,
quantitative PCR using fluorogenic probe detection was performed for the RGS21 transcript, normalized to 18S rRNA signal, and expressed as the percentage
of RGS21 expression observed in control 16HBE cells stably transfected with empty lentivirus. B, 16HBE cells were stably transfected with either empty lentivirus
(Empty) or one of three, RGS21-directed shRNA-expressing lentiviruses (#59, #61, #63), as indicated. Inhibition of forskolin-stimulated cAMP production by
treatment with the indicated concentrations of denatonium-B were determined 24 h post-transfection by detection of GloSensor-dependent luminescence.
Asterisks denote statistically significant differences from empty vector, p  0.01 (one-way analysis of variance with Dunnett’s multiple comparison test). C, net
peak intracellular calcium production by 16HBE cells stably expressing the indicated lentiviruses, as elicited by treatment with the indicated concentrations of
denatonium-B, was determined using calcium indicator dye and FLIPR detection (relative fluorescence units, RFU). D, isoproterenol-stimulated cAMP produc-
tion is not perturbed by shRNA-mediated RGS21 knockdown. Cells were treated exactly as described in panel B. Isoproterenol-induced cAMP production was
detected by GloSensor-dependent luminescence. EC50 values for isoproterenol were 4.4 (95% CI 3.6 –5.5 nM), 3.7 2.9 – 4.8 nM), 5.2 (4.4 – 6.1 nM), and 3.2 nM
(2.4 – 4.1 nM) for 16HBE cells expressing empty vector control, shRNA#59, shRNA#61, or shRNA#63, respectively. E, parental 16HBE cells were transfected with
nonspecific (Control) or RGS21-directed short-interfering RNA oligonucleotide duplexes (siRNA), prior to measurement of denatonium-B-stimulated calcium
flux as in panel C. *, p  0.03 (unpaired Student’s t test).
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stream components of the gustatory signaling cascade (31–34),
suggesting a role for RGS21 in negatively regulating tastant sig-
nal transduction in multiple cell types.
In identifying a human airway epithelial cell line (16HBE)
that co-expresses RGS21, bitter tastant receptors, and down-
stream tastant signaling proteins, we have established that
RGS21 indeed serves to blunt intracellular signaling by at least
one tastant agonist, namely the bitterant denatonium. As lin-
gual epithelium-derived taste bud cells are notoriously difficult
to maintain in culture (82), our results suggest that established,
immortalized lung epithelial cells may present a useful alterna-
tive system in which to study the action of RGS21 and other
modulatory molecules on gustatory signal transduction using
endogenous machinery (e.g. avoiding receptor and/or effector
overexpression); however, it is possible that the signaling cas-
cade in airway cells is different from that in taste bud cells
because of differing subcellular environments and/or down-
stream effectors. In the taste bud, it is likely that RGS21 and/or
other RGS proteins help to dampen signaling so that the gusta-
tory system is not overwhelmed when molecules are abundant
on the lingual epithelium. In the airway, detection of bitter tas-
tants is hypothesized to help with mucus clearance of irritants
by increasing cilia beat frequency (33, 34); thus, the role of
RGS21 in lung epithelium may be to regulate mucus clearance
by cillated airway cells in response to bitter irritants.
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